A recent study published in BMJ Mental Health reveals that less than half of children and adolescents prescribed antipsychotic medications have a documented mental health condition justifying their use.
The research found that about 20% of young patients received older antipsychotics like Haldol and Thorazine without any recorded history of mental illness.
Additionally, newer antipsychotics such as Seroquel and Zyprexa were frequently prescribed off-label for conditions lacking federal approval, raising safety concerns.
The study showed that antipsychotic prescriptions increased in youth between 2006 and 2021, but only 47% had diagnoses recognized by U.K. guidelines for such treatment.
Alarmingly, 19% had no relevant mental health diagnosis, with more than 60% of these linked to autism, a common off-label use for these drugs.
The researchers also highlighted that many patients did not receive recommended monitoring care, including blood tests, putting them at risk for side effects like sedation, movement disorders, and potentially serious neurological and organ health problems.
Experts warn that inconsistent adherence to prescribing guidelines and the complexity of safety protocols contribute to these issues. This study underscores the urgent need for stricter oversight and careful evaluation of antipsychotic use in children and teens to ensure safe and appropriate treatment.
Read more:
